• By Joel Streed

Drug Offers New Hope For Colon Cancer Patients

January 17, 2012

Maybe it's your son or daughters graduation, or the birth of a new grandchild.  For those living with advanced cancer, being able to live to see a significant milestone is often a goal.  Now, a new investigational drug called Regorafenib has been shown to shrink tumor size and improve overall survival in patients with metastatic colorectal cancer. Research was presented at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology by Axel Grothey, M.D. of Mayo Clinic.


Please login or register to post a comment.